Search

everythinglearnresearchcommunity

for

Search:↓

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Antioxidants can help improve hair growth in people with alopecia areata.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Improving oral health may help hair regrowth in children with alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Alopecia areata affects life quality differently based on its severity.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.